1. Home
  2. CSPI vs BNR Comparison

CSPI vs BNR Comparison

Compare CSPI & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CSP Inc.

CSPI

CSP Inc.

HOLD

Current Price

$9.15

Market Cap

85.6M

Sector

Technology

ML Signal

HOLD

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$8.52

Market Cap

76.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSPI
BNR
Founded
1968
2014
Country
United States
China
Employees
N/A
N/A
Industry
EDP Services
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
85.6M
76.5M
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
CSPI
BNR
Price
$9.15
$8.52
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
23.9K
22.5K
Earning Date
05-08-2026
06-05-2026
Dividend Yield
1.15%
N/A
EPS Growth
75.00
N/A
EPS
0.04
N/A
Revenue
$58,730,000.00
N/A
Revenue This Year
N/A
$111.65
Revenue Next Year
N/A
N/A
P/E Ratio
$217.75
N/A
Revenue Growth
6.36
N/A
52 Week Low
$7.55
$3.06
52 Week High
$15.00
$41.72

Technical Indicators

Market Signals
Indicator
CSPI
BNR
Relative Strength Index (RSI) 50.89 37.48
Support Level $9.02 $8.04
Resistance Level $10.15 $9.90
Average True Range (ATR) 0.66 0.77
MACD -0.02 0.23
Stochastic Oscillator 64.76 51.87

Price Performance

Historical Comparison
CSPI
BNR

About CSPI CSP Inc.

CSP Inc develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments, namely Technology Solutions, where the company focuses on value-added reseller integrated solutions, including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company designs, manufactures, and delivers products and services to customers that require specialized cybersecurity services, networking, and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates the majority of its revenue from the Americas.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

Share on Social Networks: